Advertisement

Help
You are here: Rediff Home » India » Business » Business Headline » Report
Search:  Rediff.com The Web
Advertisement
   Discuss   |      Email   |      Print | Get latest news on your desktop

Daiichi open offer for Ranbaxy ends
BS Reporter in Mumbai
Related Articles
Orchid founder may buy back stake from Ranbaxy
Ranbaxy, Daiichi confirm deal; allay market rumour
Singhs sell out entire stake in Ranbaxy to Daiichi
 
 · My Portfolio  · Live market report  · MF Selector  · Broker tips
Get Business updates:What's this?
Advertisement
September 05, 2008 11:10 IST
Japanese drug maker Daiichi Sankyo's open offer to acquire an additional 20 per cent stake in Ranbaxy Laboratories [Get Quote] ended on Thursday.

Ranbaxy's shares rose by 0.65 per cent on Thursday to close at Rs 493.55 a share, below the offer price of Rs 737 a share. 

Two days ago, it had been reported that institutional investors Life Insurance Corporation and General Insurance Corporation, which between them hold 16.43 per cent in Ranbaxy, offered to sell their stake.

In June, Daiichi Sankyo entered into a deal with Ranbaxy to acquire the 34.8 per cent stake held by Malvinder Mohan Singh's family, the promoters.

Daichii Sankyo's plan was to acquire up to 92.1 million shares through the open offer to have a controlling majority stake in the pharmaceutical major with a cumulative stake of about 55 per cent.

Last month, the Foreign Investment Promotion Board had approved the acquisition of Ranbaxy by Japan's Daiichi Sankyo.
Powered by

 Email  |    Print   |   Get latest news on your desktop

© 2008 Rediff.com India Limited. All Rights Reserved. Disclaimer | Feedback